Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 201 - 235 av 235 resultater
Tid
Selskap
Tittel
Sektor
Kategori
15 Jul 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics optimise l'analyse statistique et introduit une analyse intermédiaire dans l'étude de phase IIb ALLOB en cours dans les fractures du tibia à haut risque
20103010 Biotechnology
Other subject
30 Jun 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA: Information on the total number of voting rights and shares
20103010 Biotechnology
Change in Capital
30 Jun 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
20103010 Biotechnology
Change in Capital
13 Jun 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics to host Extraordinary General Meeting on 13 July 2022
20103010 Biotechnology
General meeting / Board Meeting
13 Jun 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics tiendra son Assemblée Générale Extraordinaire le 13 juillet 2022
20103010 Biotechnology
General meeting / Board Meeting
01 Jun 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics Provides First Quarter 2022 Business Update
20103010 Biotechnology
Other subject
01 Jun 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics fait le point sur ses activités au premier trimestre 2022
20103010 Biotechnology
Other subject
31 May 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics signs definitive subscription agreement for a maximum of EUR 5M convertible bonds facility with ABO
20103010 Biotechnology
Other financial transaction
31 May 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics signe un accord définitif de souscription pour l’émission d’obligations convertibles d’un maximum de 5 M€ avec ABO
20103010 Biotechnology
Other financial transaction
12 May 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics entre en discussions exclusives dans le cadre d’un projet de fusion inversée avec Medsenic
20103010 Biotechnology
Mergers, Acquiqitions, Transferts
12 May 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic
20103010 Biotechnology
Mergers, Acquiqitions, Transferts
09 May 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics tiendra son Assemblée Générale Ordinaire et Assemblée Générale Extraordinaire le 8 juin 2022
20103010 Biotechnology
General meeting / Board Meeting
09 May 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics to host Annual General Meeting and Extraordinary General Meeting on 8 June 2022
20103010 Biotechnology
General meeting / Board Meeting
29 Apr 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics publie ses résultats annuels 2021
20103010 Biotechnology
Other subject
29 Apr 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics announces 2021 full year results
20103010 Biotechnology
Other subject
12 Apr 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics Secures EUR 5 Million Financing
20103010 Biotechnology
Other financial transaction
12 Apr 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics obtient un financement de 5 M€
20103010 Biotechnology
Other financial transaction
29 Mar 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
20103010 Biotechnology
Corporate life
29 Mar 2022
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics réoriente sa stratégie autour du développement d’ALLOB, son produit de thérapie cellulaire phare
20103010 Biotechnology
Corporate life
23 Mar 2022
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics SA: Transparency notification received from Nyenburgh Holding NV
20103010 Biotechnology
Corporate life
23 Mar 2022
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics SA : Notification de transparence reçue de la part de Nyenburgh Holding NV
20103010 Biotechnology
Corporate life
19 Jan 2022
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook
20103010 Biotechnology
Other subject
19 Jan 2022
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics fait le point sur ses activités au quatrième trimestre 2021 et sur ses perspectives de développement en 2022
20103010 Biotechnology
Other subject
23 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics SA: Transparency notification received from S.R.I.W. SA and Sofipôle SA
20103010 Biotechnology
Corporate life
23 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics SA : Notification de transparence reçue de la part de S.R.I.W. SA et Sofipôle SA
20103010 Biotechnology
Corporate life
10 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics SA : Notification de transparence reçue de la part de Nyenburgh Holding NV
20103010 Biotechnology
Corporate life
10 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics SA: Transparency notification received from Nyenburgh Holding NV
20103010 Biotechnology
Corporate life
09 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
20103010 Biotechnology
Change in Capital
09 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics SA: Information on the total number of voting rights and shares
20103010 Biotechnology
Change in Capital
08 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics annonce la clôture de son placement privé
20103010 Biotechnology
Share introduction and issues
08 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics announces closing of private placement
20103010 Biotechnology
Share introduction and issues
03 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement
20103010 Biotechnology
Other subject
03 Dec 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics lève avec succès 3,3 millions d’euros dans le cadre d’un placement privé
20103010 Biotechnology
Other subject
29 Nov 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB
20103010 Biotechnology
Alliances and agreements
29 Nov 2021
07:00 CET
BONE THERAPEUTICS
Bone Therapeutics et Link Health signent un accord non-contractuel pour les droits mondiaux d’ALLOB
20103010 Biotechnology
Alliances and agreements
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
3
4
5
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva